Elsevier

Life Sciences

Volume 49, Issue 8, 1991, Pages 617-628
Life Sciences

High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors

https://doi.org/10.1016/0024-3205(91)90261-9Get rights and content

Abstract

Epidepride, (S)-N[1-ethyl-2-pyrrolidinyl)methyl]-5-iodo-2,3-dimethoxy-benzamide, the iodine analogue of isoremoxipride (FLB 457), was found to be a very potent dopamine D2 receptor antagonist. Optimal in vitro binding required incubation at 25°C for 4 h at pH 7.4 in a buffer containing 120 mM NaCl, 5 mM KCl, 2 mM CaCl2 and 1 mM MgCl2. Scatchard analysis of in vitro binding to striatal, medial frontal cortical, hippocampal and cerebellar membranes revealed a KD of 24 pM in all regions, with Bmax's of 36.7, 1.04, 0.85, and 0.37 pmol/g tissue, respectively. The Hill coefficients ranged from 0.91–1.00 in all four regions. The IC50's for inhibition of [125I]epidepride binding to striatal, medial frontal cortical, and hippocampal membranes for SCH 23390, SKF 83566, serotonin, ketanserin, mianserin, naloxone, QNB, prasozin, clonidine, alprenolol, and norepinephrine ranged from 1 μM to > 10 μM. Partial displacement of [125I]epidepride by nanomolar concentrations of clonidine was noted in the frontal cortex and hippocampus, but not in the striatum. Scatchard analysis of epidepride binding to α2 noradrenergic receptors in the frontal cortex and hippocampus revealed an apparent KD of 9 nM. At an epidepride concentration equal to the KD for the D2 receptor, i.e. 25 pM, no striatal α2 binding was seen and only 7% of the specific epidepride binding in the cortex or hippocampus was due to binding at the α2 site. Correlation of inhibition of [3H]spiperone and [125I]epidepride binding to striatal membranes by a variety of D2 ligands revealed a correlation coefficient of 0.99, indicating that epidepride labels a D2 site. In vitro autoradiography revealed high densities of receptor binding in layers V and VI of prefrontal and cingulate cortices as well as in striatum. In vivo rat brain uptake revealed a hippocampal:cerebellar and frontal cortical:cerebellar ratio of 2.2:1 which fell to 1.1:1 following haloperidol pretreatment. These properties suggest that [125I]epidepride is a superior radioligand for the in vitro and in vivo study of striatal and extrastriatal dopamine D2 receptors.

References (46)

  • J. Glowinski et al.

    Trends Neurosci

    (1984)
  • M. Camps et al.

    Neurosci

    (1989)
  • C. Kohler et al.

    Biochem Pharmacol

    (1985)
  • H.F. Kung et al.

    Nucl Med Biol

    (1988)
  • T. Brucke et al.

    Life Sci

    (1988)
  • D.R. Gehlert et al.

    Eur J Pharmacol

    (1984)
  • H. Hall et al.

    Eur J Pharmacol

    (1985)
  • C. Kohler et al.

    Eur J Pharmacol

    (1986)
  • P.M. Sanchez-Roa et al.

    Life Sci

    (1989)
  • N. El Tayar et al.

    Eur J Med Chem

    (1988)
  • P.J. Munson et al.

    Analytical Biochem

    (1980)
  • W. Billard et al.

    Life Sci

    (1984)
  • K.E. Flaim et al.

    Life Sci

    (1986)
  • M.S. Lidow et al.

    Neuroscience

    (1991)
  • M.J. Bannon et al.

    Pharmacol Rev.

    (1983)
  • G.P. Reynolds

    Br J Psychiat

    (1989)
  • M-P. Martres et al.

    Science

    (1985)
  • A.J. MacLennan et al.

    Psychopharmacol

    (1988)
  • C. Charuchinda et al.

    J Neurosci

    (1987)
  • C.A. Altar et al.

    J Pharm Exp Ther

    (1985)
  • J.F. Tallman et al.

    Nature

    (1981)
  • J.J. Enna et al.

    J Neurochem

    (1977)
  • H.H. Coenen et al.

    Eur J Nucl Med

    (1988)
  • Cited by (0)

    View full text